Background: Surgical management of colorectal cancer relies on accurate identification of
Hyperspectral imaging systems have become commercially available with the ability to capture high-resolution spectral signals from across the optical spectrum, including the visible (VIS) through near-infrared (NIR) and shortwave-infrared (SWIR) wavelengths. Compared with conventional spectroscopy, hyperspectral spectroscopy (HSS) covers a contiguous portion of the optical spectrum, thus including more spectral bands and providing higher resolution. Fields outside of medicine, including astronomy and satellite imaging, have employed this technology with significant benefits. 2 The applications for hyperspectral sensing for biomedical applications are emerging as areas of increased academic and commercial interest.
For biomedical applications, inhomogeneity of biologic structures's leads to light scattering that can give information regarding the composition of the underlying tissue. 2 The depth of penetration varies from millimeters for visible light to as deep as multiple centimeters for NIR light, which enables capture of data from multiple tissue levels simultaneously. 3, 4 At every level, light scattering is dependent upon features of the underlying tissue, including the cellular crowding, amount of blood flow and metabolic activity, and presence of specific physiologic substrates, and can allow for distinction between tissue types. [5] [6] [7] Colorectal cancer is an excellent target for hyperspectral spectroscopy. It is the fourth most common cancer in the United States, and is the second leading cause of cancer death, accounting for 49,000 deaths annually. 8 Complete surgical resection is the mainstay of therapy in early stage disease. However, complete surgical resection relies on the ability to detect all foci of tumor, including lymph nodes and peritoneal implants. Furthermore, sampling and interpretive errors may lead to disagreement in a small proportion of the patients. 9 The use of laparoscopic and robotic surgery has increased with increasingly improved oncologic and survival outcomes in minimally invasive colectomy for cancer. 10 However, the use of laparoscopy may compro- Following classifier construction, data were cross-validated by using 50% of the data as a training set and testing on the remaining 50%.
A Monte Carlo method was used to randomly select data for inclusion into either the training or testing data set over a series of 100 iterations. Following Monte Carlo iterations, results were averaged and used to generate a representative receiver operating characteristics (ROC) curve.
| RESULTS
Fifteen patients (11 male, 4 female), ages 27-90 years, were prospectively enrolled in the study (Table 1) . Surgical resection of the affected colon segment was successful in all patients. Fourteen (93%) patients had preoperative colonoscopy demonstrating concerning polyps or a colonic mass. A total of three patients were excluded. One patient underwent resection for inflammatory bowel disease (IBD) and polyps;
however, postoperative pathologic examination revealed no evidence of adenocarcinoma. One patient was excluded after pathologic examination only revealed high grade dysplasia. A third subject was excluded after receiving Indocyanine Green (ICG) for intraoperative blood flow assessment which interfered with spectral absorbance patterns at wavelengths between 800 and 900 nm. Subsequent analysis of the spectral waveform for this subject demonstrated a significantly altered peak in the expected wavelength for ICG, compared with the remaining subjects. Since ICG administration is not standard practice and caused a demonstrable difference in the waveform, this subject was therefore excluded. For all included patients, pathologic examination of resected specimens confirmed the diagnosis of adenocarcinoma. As this was a proof of concept study, both methods were also compared with the lowest threshold of simple chance detection (Figures 2 and 3), with both demonstrating better than chance detection rates.
The rate of detection with the 5% false positive threshold was 80.76% and increased to 91.97% when the false positive rate was increased to 10%. For specimens imaged extraluminally, a series of thresholds for cancer detection was used to create an ROC curve, which demonstrated detection rates significantly greater than chance ( Figure 3 ). When this false positive rate was set to 10%, the tumor detection rate increased to 61.68%. When a cutoff threshold for 5% false positive rate was set, the rate of cancer detection was 30.73%.
To optimize classification of tumors by intraluminal detection we explored an additional classification method in a post hoc manner for detection rate analysis. Support vector machines (SVM) classification method allows for non-linear borders between groups of data. When this method was applied to the intraluminal data, again using two classes (normal and tumor), the detection rate was 86% with 5% false positive and 91% with 10% false positive rate.
The importance of particular ranges (i.e. VIS vs SWIR vs NIR) of the captured spectra was also examined. In order to do so, an LDA classifier was constructed using elements from only the VIS through NIR range, the VIS through SWIR range (all captured data consistent with results listed above) and the SWIR range only for data collected from intraluminal methods only. Following classification, an iterated
Monte Carlo method was used to construct separate ROC curves for each classifier (Figure 4 ). Classification methods using data restricted to the VIS-NIR range result in significantly lower detection rates of 62% and 74% at 5% and 10% false positive rates, respectively. Detection rates when using SWIR only data were 77% and 90.5% at 5% and 
| DISCUSSION
The mainstay of surgical treatment of colorectal cancer relies on resection of all known disease. 11 Currently, surgeons rely on visual inspection and manual palpation to guide the extent of resection of colorectal surgery, and the latter is absent when a laparoscopic or robotic approach is employed. Technology that discriminates tissue based on intrinsic differences in cell biology and vascular supply could be a valuable adjunct in the operating room. 12 5 ). In many cases, accuracy from the SWIR only data approached Since this is a narrower range than including all data, such a study would likely need to include a larger number of tumor specimens and spectroscopic readings.
In this work we have used machine-learning algorithms to classify tissues empirically on the basis of their spectral features, without granular knowledge of the nature of the differences between them.
Intraluminal detection accuracy of 92% at 10% false positive rate demonstrate a highly accurate system that could be used to augment endo- 27 We believe our results, in conjunction with previous results reporting high accuracy rates in intraluminal tumors in resected specimens, suggest the useful role of hyperspectral sensing in this setting. 22 It is important to note the limitations of this study to inform the next phase of hyperspectral research. Within our study, the typical tumor size was greater than 3 cm and all lesions were determined to be adenocarcinoma based on histologic evaluation. As such, we do not have the ability to assess the possible use of hyperspectral sensing in identifying adenomas or determining their malignant potential. Additionally, though the largest series reported to date, this study still only samples a small patient population and larger studies are necessary to determine the generalizability of spectral shifts of tumors in the larger population. Larger sample sizes are needed to more accurately define positive and negative spectral signals, as well as account for biologic signal heterogeneity. As our next steps, we will be using HSS for detecting peritoneal tumor implants, lymph node metastasis & lateral margins for rectal cancer. Use of HSS for these tumors should behave more like intraluminal reading and the sensitivity of 92% is reasonable for that.
| CONCLUSION
Hyperspectral sensing can reliably detect tumors in resected colon specimens, especially when collected from intraluminal measurements.
Sensitivity rates exceed 90% with 90% specificity. Spectral information within the shortwave infrared range appears to drive increased detection rates, supporting the further investigation of cellular changes in neoplastic disease that alter fluorescence in this range. This research offers promising results for a diagnostic technology that is non-ionizing and does not require the use of contrast agents to achieve accurate colorectal cancer detection.
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